How new therapies are transforming the treatment of juvenile idiopathic arthritis

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup